{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:32:27Z","timestamp":1773189147476,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2003,10,12]],"date-time":"2003-10-12T00:00:00Z","timestamp":1065916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1038\/nbt887","type":"journal-article","created":{"date-parts":[[2003,10,12]],"date-time":"2003-10-12T17:17:15Z","timestamp":1065979035000},"page":"1328-1335","source":"Crossref","is-referenced-by-count":143,"title":["E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models"],"prefix":"10.1038","volume":"21","author":[{"given":"Yaohe","family":"Wang","sequence":"first","affiliation":[]},{"given":"Gunnel","family":"Hallden","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Hill","sequence":"additional","affiliation":[]},{"given":"Arthi","family":"Anand","sequence":"additional","affiliation":[]},{"given":"Ta-Chiang","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Jennelle","family":"Francis","sequence":"additional","affiliation":[]},{"given":"Gabriel","family":"Brooks","sequence":"additional","affiliation":[]},{"given":"Nick","family":"Lemoine","sequence":"additional","affiliation":[]},{"given":"David","family":"Kirn","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,10,12]]},"reference":[{"key":"BFnbt887_CR1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/89901","volume":"7","author":"D Kirn","year":"2001","unstructured":"Kirn, D., Martuza, R.L. & Zwiebel, J. Replication-selective virotherapy for cancer: biological principles, risk management and future directions. Nat. Med. 7, 781\u2013787 (2001).","journal-title":"Nat. Med."},{"key":"BFnbt887_CR2","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1172\/JCI9761","volume":"105","author":"D Kirn","year":"2000","unstructured":"Kirn, D. Replication-selective micro-organisms: fighting cancer with targeted germ warfare. J. Clin. Invest. 105, 836\u2013838 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnbt887_CR3","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1038\/sj.onc.1204094","volume":"19","author":"D Kirn","year":"2000","unstructured":"Kirn, D. Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer. Oncogene 19, 6660\u20136668 (2000).","journal-title":"Oncogene"},{"key":"BFnbt887_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.274.5286.373","volume":"274","author":"JR Bischoff","year":"1996","unstructured":"Bischoff, J.R. et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells [see comments]. Science 274, 373\u2013376 (1996).","journal-title":"Science"},{"key":"BFnbt887_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nm0697-639","volume":"3","author":"C Heise","year":"1997","unstructured":"Heise, C. et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents [see comments]. Nat. Med. 3, 639\u2013645 (1997).","journal-title":"Nat. Med."},{"key":"BFnbt887_CR6","first-page":"1498","volume":"59","author":"D Yu","year":"1999","unstructured":"Yu, D., Sakamoto, G. & Henderson, D.R. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res. 59, 1498\u20131504 (1999).","journal-title":"Cancer Res."},{"key":"BFnbt887_CR7","first-page":"4200","volume":"59","author":"D Yu","year":"1999","unstructured":"Yu, D., Chen, Y., Seng, M., Dilley, J. & Henderson, D.R. The addition of adenovirus region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts. Cancer Res. 59, 4200\u20134203 (1999).","journal-title":"Cancer Res."},{"key":"BFnbt887_CR8","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/80474","volume":"6","author":"C Heise","year":"2000","unstructured":"Heise, C. et al. An adenovirus E1A mutant that demonstrates potent and selective antitumoral efficacy. Nat. Med. 6, 1134\u20131139 (2000).","journal-title":"Nat. Med."},{"key":"BFnbt887_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1089\/hum.1998.9.9-1323","volume":"9","author":"SO Freytag","year":"1998","unstructured":"Freytag, S.O., Rogulski, K.R., Paielli, D.L., Gilbert, J.D. & Kim, J.H. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy [see comments]. Hum. Gene Ther. 9, 1323\u20131333 (1998).","journal-title":"Hum. Gene Ther."},{"key":"BFnbt887_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.onc.1203251","volume":"19","author":"J Fueyo","year":"2000","unstructured":"Fueyo, J. et al. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 19, 2\u201312 (2000).","journal-title":"Oncogene"},{"key":"BFnbt887_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1172\/JCI9180","volume":"106","author":"T Kurihara","year":"2000","unstructured":"Kurihara, T., Brough, D.E., Kovesdi, I. & Kufe, D.W. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. J. Clin. Invest. 106, 763\u2013771 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnbt887_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1535-6108(02)00060-0","volume":"1","author":"L Johnson","year":"2002","unstructured":"Johnson, L. et al. Selectively-replicating adenovirus targeting deregulated E2F activity are potent antitumor agents. Cancer Cell 1, 325\u2013337 (2002).","journal-title":"Cancer Cell"},{"key":"BFnbt887_CR13","first-page":"1490","volume":"63","author":"J Jakubczak","year":"2003","unstructured":"Jakubczak, J. et al. An oncolytic adenovirus selective for retinoblastoma protein-defective tumors. Cancer Res. 63, 1490\u20131499 (2003).","journal-title":"Cancer Res."},{"key":"BFnbt887_CR14","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1128\/JVI.74.13.6147-6155.2000","volume":"74","author":"K Doronin","year":"2000","unstructured":"Doronin, K. et al. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein. J. Virol. 74, 6147\u20136155 (2000).","journal-title":"J. Virol."},{"key":"BFnbt887_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nbt1101-1035","volume":"19","author":"M Ramachandra","year":"2001","unstructured":"Ramachandra, M. et al. Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy. Nat. Biotechnol. 19, 1035\u20131041 (2001).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt887_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sj.gt.3301377","volume":"8","author":"D Kirn","year":"2001","unstructured":"Kirn, D. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther. 8, 89\u201398 (2001).","journal-title":"Gene Ther."},{"key":"BFnbt887_CR17","first-page":"7464","volume":"61","author":"T DeWeese","year":"2001","unstructured":"DeWeese, T. et al. A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res. 61, 7464\u20137472 (2001).","journal-title":"Cancer Res."},{"key":"BFnbt887_CR18","first-page":"6359","volume":"60","author":"J Nemunaitis","year":"2000","unstructured":"Nemunaitis, J. et al. Selective replication and oncolysis in p53 mutant tumors with Onyx-015, an E1B-55kDa gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res. 60, 6359\u20136366 (2000).","journal-title":"Cancer Res."},{"key":"BFnbt887_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2001.19.2.289","volume":"19","author":"J Nemunaitis","year":"2001","unstructured":"Nemunaitis, J. et al. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J. Clin. Oncol. 19, 289\u2013298 (2001).","journal-title":"J. Clin. Oncol."},{"key":"BFnbt887_CR20","first-page":"1562","volume":"20","author":"P Vasey","year":"2002","unstructured":"Vasey, P., Shulman, L., Gore, M., Kirn, D. & Kaye, S. Phase I trial of intraperitoneal Onyx-015 adenovirus in patients with recurrent ovarian carcinoma. J. Clin. Oncol. 20, 1562\u20131569 (2002).","journal-title":"J. Clin. Oncol."},{"key":"BFnbt887_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0966-842X(94)90801-X","volume":"2","author":"WS Wold","year":"1994","unstructured":"Wold, W.S., Hermiston, T.W. & Tollefson, A.E. Adenovirus proteins that subvert host defenses. Trends Microbiol. 2, 437\u2013443 (1994).","journal-title":"Trends Microbiol."},{"key":"BFnbt887_CR22","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/JVI.70.4.2431-2439.1996","volume":"70","author":"TE Sparer","year":"1996","unstructured":"Sparer, T.E. et al. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J. Virol. 70, 2431\u20132439 (1996).","journal-title":"J. Virol."},{"key":"BFnbt887_CR23","first-page":"2559","volume":"57","author":"R Rodriguez","year":"1997","unstructured":"Rodriguez, R. et al. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57, 2559\u20132563 (1997).","journal-title":"Cancer Res."},{"key":"BFnbt887_CR24","first-page":"2623","volume":"59","author":"C Heise","year":"1999","unstructured":"Heise, C., Williams, A., Xue, S., Propst, M. & Kirn, D. Intravenous administration of ONYX-015, a selectively-replicating adenovirus, induces antitumoral efficacy. Cancer Res. 59, 2623\u20132628 (1999).","journal-title":"Cancer Res."},{"key":"BFnbt887_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/sj.cgt.7700071","volume":"6","author":"C Heise","year":"1999","unstructured":"Heise, C., Williams, A., Olesch, J. & Kirn, D. Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects. Cancer Gene Ther. 6, 499\u2013504 (1999).","journal-title":"Cancer Gene Ther."},{"key":"BFnbt887_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1073\/pnas.88.5.1651","volume":"88","author":"HS Ginsberg","year":"1991","unstructured":"Ginsberg, H.S. et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88, 1651\u20131655 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt887_CR27","first-page":"237","volume":"199","author":"WS Wold","year":"1995","unstructured":"Wold, W.S., Tollefson, A.E. & Hermiston, T.W. E3 transcription unit of adenovirus. Curr. Top. Microbiol. Immunol. 199, 237\u2013274 (1995).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnbt887_CR28","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1128\/JVI.71.4.2830-2837.1997","volume":"71","author":"T Dimitrov","year":"1997","unstructured":"Dimitrov, T. et al. Adenovirus E3-10.4K\/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J. Virol. 71, 2830\u20132837 (1997).","journal-title":"J. Virol."},{"key":"BFnbt887_CR29","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1128\/JVI.67.9.5289-5298.1993","volume":"67","author":"TW Hermiston","year":"1993","unstructured":"Hermiston, T.W., Tripp, R.A., Sparer, T., Gooding, L.R. & Wold, W.S. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J. Virol. 67, 5289\u20135298 (1993).","journal-title":"J. Virol."},{"key":"BFnbt887_CR30","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.1128\/JVI.76.22.11329-11342.2002","volume":"76","author":"DL Lichtenstein","year":"2002","unstructured":"Lichtenstein, D.L., Krajcsi, P., Esteban, D.J., Tollefson, A.E. & Wold, W.S. Adenovirus RID\u03b2 subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis. J. Virol. 76, 11329\u201311342 (2002).","journal-title":"J. Virol."},{"key":"BFnbt887_CR31","first-page":"106","volume":"3","author":"LR Gooding","year":"1994","unstructured":"Gooding, L.R. Regulation of TNF-mediated cell death and inflammation by human adenoviruses. Infect. Agents Dis. 3, 106\u2013115 (1994).","journal-title":"Infect. Agents Dis."},{"key":"BFnbt887_CR32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.70.1.68-77.1996","volume":"70","author":"J Shisler","year":"1996","unstructured":"Shisler, J., Duerksen, H.P., Hermiston, T.M., Wold, W.S. & Gooding, L.R. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis. J. Virol. 70, 68\u201377 (1996).","journal-title":"J. Virol."},{"key":"BFnbt887_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1099\/0022-1317-40-1-45","volume":"40","author":"S Duncan","year":"1978","unstructured":"Duncan, S. et al. Infection of mouse liver by human adenovirus type 5. J. Gen. Virol. 40, 45\u201361 (1978).","journal-title":"J. Gen. Virol."},{"key":"BFnbt887_CR34","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1128\/JVI.74.6.2895-2899.2000","volume":"74","author":"I Ganly","year":"2000","unstructured":"Ganly, I., Mauntner, V. & Balmain, A. Productive replication of human adenoviruses in mouse epidermal cells. J. Virol. 74, 2895\u20132899 (2000).","journal-title":"J. Virol."},{"key":"BFnbt887_CR35","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.4049\/jimmunol.163.3.1516","volume":"163","author":"H Hayder","year":"1999","unstructured":"Hayder, H. et al. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin. J. Immunol. 163, 1516\u20131520 (1999).","journal-title":"J. Immunol."},{"key":"BFnbt887_CR36","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2337\/diabetes.50.5.980","volume":"50","author":"S Efrat","year":"2001","unstructured":"Efrat, S. et al. Adenovirus early region 3(E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 50, 980\u2013984 (2001).","journal-title":"Diabetes"},{"key":"BFnbt887_CR37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/JVI.68.1.453-462.1994","volume":"68","author":"J Tufariello","year":"1994","unstructured":"Tufariello, J., Cho, S. & Horwitz, M.S. The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. J. Virol. 68, 453\u2013462 (1994).","journal-title":"J. Virol."},{"key":"BFnbt887_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.gt.3300398","volume":"4","author":"DB Schowalter","year":"1997","unstructured":"Schowalter, D.B., Tubb, J.C., Liu, M., Wilson, C.B. & Kay, M.A. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo. Gene Ther. 4, 351\u2013360 (1997).","journal-title":"Gene Ther."},{"key":"BFnbt887_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/hep.510310317","volume":"31","author":"ZX Liu","year":"2000","unstructured":"Liu, Z.X., Govindarajan, S., Okamoto, S. & Dennert, G. Fas- and tumor necrosis factor receptor 1-dependent but not perforin-dependent pathways cause injury in livers infected with an adenovirus construct in mice. Hepatology 31, 665\u2013673 (2000).","journal-title":"Hepatology"},{"key":"BFnbt887_CR40","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1128\/JVI.70.8.4904-4913.1996","volume":"70","author":"P Krajcsi","year":"1996","unstructured":"Krajcsi, P. et al. The adenovirus E3-14.7K protein and the E3-10.4K\/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J. Virol. 70, 4904\u20134913 (1996).","journal-title":"J. Virol."},{"key":"BFnbt887_CR41","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1128\/JVI.65.8.4114-4123.1991","volume":"65","author":"LR Gooding","year":"1991","unstructured":"Gooding, L.R. et al. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65, 4114\u20134123 (1991).","journal-title":"J. Virol."},{"key":"BFnbt887_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S1525-0016(03)00199-0","volume":"8","author":"G Hallden","year":"2003","unstructured":"Hallden, G. et al. Novel immunocompetent models for assessment of oncolytic adenovirus. Molecular Therapy 8, 412\u2013424 (2003).","journal-title":"Molecular Therapy"},{"key":"BFnbt887_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1099\/0022-1317-40-1-45","volume":"40","author":"S Duncan","year":"1978","unstructured":"Duncan, S. et al. Infection of mouse liver by human adenovirus type 5. J. Gen. Virol. 40, 45\u201361 (1978).","journal-title":"J. Gen. Virol."},{"key":"BFnbt887_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0966-842X(94)90801-X","volume":"2","author":"WS Wold","year":"1994","unstructured":"Wold, W.S., Hermiston, T.W. & Tollefson, A.E. Adenovirus proteins that subvert host defenses. Trends Microbiol. 2, 437\u2013443 (1994).","journal-title":"Trends Microbiol."},{"key":"BFnbt887_CR45","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.4049\/jimmunol.163.3.1516","volume":"163","author":"H Hayder","year":"1999","unstructured":"Hayder, H. et al. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin. J. Immunol. 163, 1516\u20131520 (1999).","journal-title":"J. Immunol."},{"key":"BFnbt887_CR46","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1128\/JVI.70.8.4904-4913.1996","volume":"70","author":"P Krajcsi","year":"1996","unstructured":"Krajcsi, P. et al. The adenovirus E3-14.7K protein and the E3-10.4K\/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J. Virol. 70, 4904\u20134913 (1996).","journal-title":"J. Virol."},{"key":"BFnbt887_CR47","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1128\/JVI.67.9.5289-5298.1993","volume":"67","author":"TW Hermiston","year":"1993","unstructured":"Hermiston, T.W., Tripp, R.A., Sparer, T., Gooding, L.R. & Wold, W.S. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J. Virol. 67, 5289\u20135298 (1993).","journal-title":"J. Virol."},{"key":"BFnbt887_CR48","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/sj.gt.3301512","volume":"8","author":"T Reid","year":"2001","unstructured":"Reid, T. et al. Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Ther. 8, 1618\u20131626 (2001).","journal-title":"Gene Ther."},{"key":"BFnbt887_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/cimm.1994.1218","volume":"157","author":"DB Day","year":"1994","unstructured":"Day, D.B., Zachariades, N.A. & Gooding, L.R. Cytolysis of adenovirus-infected murine fibroblasts by IFN-\u03b3-primed macrophages is TNF- and contact-dependent. Cell Immunol. 157, 223\u2013238 (1994).","journal-title":"Cell Immunol."},{"key":"BFnbt887_CR50","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1172\/JCI9973","volume":"105","author":"T Hermiston","year":"2000","unstructured":"Hermiston, T. Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer. J. Clin. Invest. 105, 1169\u20131175 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnbt887_CR51","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/78638","volume":"6","author":"F Khuri","year":"2000","unstructured":"Khuri, F. et al. A controlled trial of Onyx-015, an E1B gene-deleted adenovirus, in combination with chemotherapy in patients with recurrent head and neck cancer. Nat. Med. 6, 879\u2013885 (2000).","journal-title":"Nat. Med."},{"key":"BFnbt887_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2407-1-7","volume":"1","author":"I Nagtegaal","year":"2001","unstructured":"Nagtegaal, I. et al. Local and distant recurrences in rectal cancer patients predicted by the immune response; a histopathological and immunohistochemical study. BMC Cancer 1, 7\u201311 (2001).","journal-title":"BMC Cancer"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt887","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:57:17Z","timestamp":1684439837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,12]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["BFnbt887"],"URL":"https:\/\/doi.org\/10.1038\/nbt887","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,12]]}}}